The prevalence and clinical features of Wilson's disease in Scotland were investigated. Thirty three cases were identified but adequate information was available on only 28. In 1989, the prevalence rate was 4 per million.
The increased estimated prevalence for Wilson's disease produced an uncomfortable concern in the minds of many gastroenterologists and neurologists who were apparently failing to detect the majority of cases of this treatable disorder. 9 Despite much quoted worldwide prevalence data,3 very few complete epidemiological studies have been carried out,"''2 most studies being restricted to groups of patients to determine the gene frequency. [13] [14] [15] [16] (Table III) .
METHODS OF DIAGNOSIS
At presentation all symptomatic patients had abnormal clinical signs. Kayser-Fleischer rings were present in 20, absent in four, and not looked for in another four (Table IV) . Six patients (2 1%) were asymptomatic siblings of patients with Wilson's disease. All patients had routine blood tests including liver function tests (LFTs), which were abnormal in 79% of the total group. All the hepatic group patients had abnormal LFTs, and surprisingly all the asymptomatic patients had considerably raised transaminase activities (three to four times normal). Serum copper was low in all patients except the two who presented with acute liver failure. In 75% of all patients, urinary copper excretion was also estimated. Serum caeruloplasmin values were checked in 20 patients (71%) and were uniformly low. On presentation, the peripheral blood count was abnormal in 32% of all patients. Fourteen patients had a liver biopsy performed on presentation, two patients at necropsy after presentation with acute liver failure, two patients at necropsy after chronic liver failure, and in 10 patients a liver biopsy was never performed (Table V) . At presentation, all of the patients in the hepatic group who had had a liver biopsy were found to have either fibrosis or cirrhosis, four of seven in the neurological group had cirrhosis, and all three asymptomatic patients were found to have either mild fibrosis or normal liver histology. Hepatic copper was measured in eight patients on presentation (one in a necropsy sample) and was found to be mean (range) 1386 (136-4177) ig/g dry weight of tissue (normal reference range [ig/g dry weight of tissue) (Table VI) . TREATMENT All patients except the two who presented with fulminant liver failure were begun on penicillamine. This was stopped in nine patients because of an abnormal peripheral blood count (6) , rash (2) , and patient's own choice (1). Four of the six patients who developed an abnormal blood count had a moderate thrombocytopenia (platelet count 80-150 000x 106/1) that seemed to have been the result of drug therapy, and two patients had a pancytopenia that was probably caused by hypersplenism rather than drugs. Seven patients were established on trientine without any further problems.
Only one patient had received a short course of oral zinc therapy. Five patients did not comply with regular drug treatment and could therefore be considered to have been inadequately treated.
One patient who defaulted from follow up and (Table  VIII) . One of the patients who died from chronic liver failure complicated by massive variceal bleeding had been advised inappropriately by a general physician to stop penicillamine four months before his death as he was thought to have drug induced thrombocytopenia rather than the true cause of hypersplenism. Another unfortunate patient, an asymptomatic case, had stopped penicillamine on her own accord 18 months before presenting in acute liver failure.
Nineteen of the 28 patients were alive at the end of the study and had been followed up for a mean of 13.7 years (range 2-33 years). Twelve were well and symptom free, four were disabled by neurological problems, one had chronic liver failure, and two had both severe chronic liver failure and neurological disability. (2) Acute liver failure (4) Pneumonia associated with immobility (4) Pulmonary aspiration during a seizure (1) Acute pancreatitis (1)
Discussion
We have found from this epidemiological study that the prevalence rate for Wilson's disease in Scotland is 4 12 Several patients in our study did not receive optimal hospital supervision and it is of some concern that at the end of the study period five patients were not attending a hospital clinic on a regular basis. Many of those attending hospital, however, did not receive ideal treatment, especially specialised supervision of their chronic liver disease from which many patients died. To ensure the best prognosis, patients with Wilson's disease should attend a specialist hospital clinic for regular review. This is of particular importance for asymptomatic patients detected by screening, as adequate treatment ensures an excellent long term prognosis.37
